Evaluating Metabolite-Based Biomarkers for Early Diagnosis of Pancreatic Cancer: A Systematic Review

Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with five-year survival rates around 10%. The only curative option remains complete surgical resection, but due to the delay in diagnosis, less than 20% of patients are eligible for surgery. Therefore, discovering diagnostic bi...

Descripción completa

Detalles Bibliográficos
Autores principales: Perazzoli, Gloria, García-Valdeavero, Olga M., Peña, Mercedes, Prados, Jose, Melguizo, Consolación, Jiménez-Luna, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384620/
https://www.ncbi.nlm.nih.gov/pubmed/37512579
http://dx.doi.org/10.3390/metabo13070872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384620/
https://www.ncbi.nlm.nih.gov/pubmed/37512579
http://dx.doi.org/10.3390/metabo13070872

Ejemplares similares